Axsome Therapeutics News and Activities

Presence

Axsome Therapeutics develops and sells medicines for central nervous system conditions. Its products and clinical programs support patients, healthcare providers, and health systems in areas such as depression, sleep disorders, and migraine.

Axsome Therapeutics products and services overview:

CNS medicines
Depression treatments
Sleep disorder therapies
Migraine treatments
Neuroscience research

Revenue: ~$413 million

Employees: 500

Headquarters: New York, United States (USA)

Axsome Therapeutics is one of the...

Axsome Therapeutics is a company listed under the stock ticker AXSM (US).

Executives

View the org chart displaying its 43 main executives

Most searched biographies at Axsome Therapeutics

Popular executive movements at Axsome Therapeutics

Upendra Topiwala, who was Director, Regulatory Affairs, Advertising & Promotion, is promoted to Senior Director, Regulatory Affairs Advertising and Promotion (posted on April 14 2026).
Jon Foster, who was Executive Director, Business Development, is promoted to Associate Vice President of Business Development (posted on April 14 2026).
Nicolas Aguirre, who was Senior Director, Clinical Operations, is promoted to Executive Director, Clinical Operations (posted on April 14 2026).

Create your alert
to follow the executive moves at Axsome Therapeutics.